Role of Env in Resistance of Feline Immunodeficiency Virus (FIV)-Infected Cats to Superinfection by a Second FIV Strain as Determined by Using a Chimeric Virus

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Virology

• Publication date

  2007-07-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.01064-07PMID 17634241PMCID PMC2045460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vaccine protection against feline immunodeficiency virus: setting the challenge.

  2007cited by this paper
• CD8+ T-cell responses to different HIV proteins have discordant associations with viral load

  2007cited by this paper
• FIV as a Model for AIDS Vaccine Studies

  2006cited by this paper
• FIV as a Model for HIV: An Overview

  2006cited by this paper
• Dual HIV infection.

  2006cited by this paper
• FIV as a Model for AIDS Pathogenesis Studies

  2006cited by this paper
• Immunological correlates of protection from HIV infection and disease

  2006cited by this paper
• In vivo Models of HIV Disease and Control

  2006cited by this paper
• HIV vaccines.

  2006cited by this paper
• Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus.

  2006cited by this paper
• Evidence for Frequent Reinfection with Human Immunodeficiency Virus Type 1 of a Different Subtype

  2005cited by this paper
• Evaluation of live feline immunodeficiency virus vaccines with modified antigenic properties.

  2005cited by this paper
• HIV vaccine design: insights from live attenuated SIV vaccines

  2005cited by this paper
• [HIV vaccines].

  2005cited by this paper
• Frequency of HIV-1 dual subtype infections, including intersubtype superinfections, among injection drug users in Bangkok, Thailand

  2005cited by this paper
• HIV superinfection.

  2005cited by this paper
• Evaluation of feline immunodeficiency virus ORF-A mutants as candidate attenuated vaccine.

  2005cited by this paper
• CD8+ Lymphocytes Do Not Mediate Protection against Acute Superinfection 20 Days after Vaccination with a Live Attenuated Simian Immunodeficiency Virus

  2005cited by this paper
• Requirement of diverse T-helper responses elicited by HIV vaccines: induction of highly targeted humoral and CTL responses

  2004cited by this paper
• Heterologous Envelope Immunogens Contribute to AIDS Vaccine Protection in Rhesus Monkeys

  2004cited by this paper
• HIV vaccine design and the neutralizing antibody problem

  2004cited by this paper
• Transmission and immunopathogenesis of FIV in cats as a model for HIV.

  2003cited by this paper
• AIDS Vaccination Studies Using an Ex Vivo Feline Immunodeficiency Virus Model: Protection from an Intraclade Challenge Administered Systemically or Mucosally by an Attenuated Vaccine

  2003cited by this paper
• Intersubtype Human Immunodeficiency Virus Type 1 Superinfection following Seroconversion to Primary Infection in Two Injection Drug Users

  2002cited by this paper
• A patient with HIV-1 superinfection.

  2002cited by this paper
• HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus

  2002cited by this paper
• Prospects for vaccine protection against HIV-1 infection and AIDS.

  2002cited by this paper
• Evolution of Replication Efficiency following Infection with a Molecularly Cloned Feline Immunodeficiency Virus of Low Virulence

  2002cited by this paper
• Mechanisms of protection against simian immunodeficiency virus infection.

  2002cited by this paper
• Kinetics of Early FIV Infection in Cats Exposed via the Vaginal versus Intravenous Route

  2002cited by this paper
• Early Pathogenesis of Transmucosal Feline Immunodeficiency Virus Infection

  2002cited by this paper
• Persistence of Pathogenic Challenge Virus in Macaques Protected by Simian Immunodeficiency Virus SIVmacΔnef

  2001cited by this paper
• AIDS Vaccination Studies Using an Ex Vivo Feline Immunodeficiency Virus Model: Reevaluation of Neutralizing Antibody Levels Elicited by a Protective and a Nonprotective Vaccine after Removal of Antisubstrate Cell Antibodies

  2001cited by this paper
• During Readaptation In Vivo, a Tissue Culture-Adapted Strain of Feline Immunodeficiency Virus Reverts to Broad Neutralization Resistance at Different Times in Individual Hosts but through Changes at the Same Position of the Surface Glycoprotein

  2001cited by this paper
• The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1.

  2000cited by this paper
• Live Attenuated HIV Vaccines: A Proposal for Further Research and Development

  2000cited by this paper
• Relationship of Lymphoid Lesions to Disease Course in Mucosal Feline Immunodeficiency Virus Type C Infection

  2000cited by this paper
• Identification of a window period for susceptibility to dual infection with two distinct human immunodeficiency virus type 2 isolates in a Macaca nemestrina (pig-tailed macaque) model.

  1999cited by this paper
• Kinetics of Replication of a Partially Attenuated Virus and of the Challenge Virus during a Three-Year Intersubtype Feline Immunodeficiency Virus Superinfection Experiment in Cats

  1999cited by this paper
• Protection by Live, Attenuated Simian Immunodeficiency Virus against Heterologous Challenge

  1999cited by this paper
• The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses

  1998cited by this paper
• Workshop Summary: Lessons from the Cat: Feline Immunodeficiency Virus as a Tool to Develop Intervention Strategies against Human Immunodeficiency Virus Type 1

  1998cited by this paper
• Autologous and Heterologous Neutralization Analyses of Primary Feline Immunodeficiency Virus Isolates

  1998cited by this paper
• Env-Independent Protection Induced by Live, Attenuated Simian Immunodeficiency Virus Vaccines

  1998influential reference
• Temporal Analyses of Virus Replication, Immune Responses, and Efficacy in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine

  1998cited by this paper
• Identification of Highly Attenuated Mutants of Simian Immunodeficiency Virus

  1998cited by this paper
• Studies of AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boosted

  1997cited by this paper
• Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection

  1996cited by this paper
• Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1

  1996cited by this paper
• Neutralization of feline immunodeficiency virus by polyclonal feline antibody: simultaneous involvement of hypervariable regions 4 and 5 of the surface glycoprotein

  1995cited by this paper
• FIV as a Model for AIDS Vaccination

  1994cited by this paper
• A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization

  1993cited by this paper
• Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope

  1993cited by this paper
• Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.

  1992cited by this paper
• Nucleotide sequence and genomic organization of feline immunodeficiency virus.

  1989cited by this paper
• Superinfection of a chimpanzee with a second strain of human immunodeficiency virus

  1987cited by this paper
• Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.

  1987cited by this paper

• Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine

  2015cites this paper
• Virus evolution in the progression of natural feline immunodeficiency virus infection

  2013cites this paper
• Feline immunodeficiency virus latency

  2013cites this paper
• Reciprocal functional pseudotyping of HIV-1 and HTLV-1 viral genomes by the heterologous counterpart envelope proteins.

  2013cites this paper
• Prior bovine immunodeficiency virus infection does not inhibit subsequent superinfection by the acutely pathogenic Jembrana disease virus.

  2010cites this paper
• An analysis of Bovine immunodeficiency virus and Jembrana disease virus infections in Bos javanicus

  2010cites this paper
• FIV vaccine development: a continuing challenge

  2008cites this paper